NXTC
NXTC
NASDAQ · Biotechnology

Nextcure Inc

$6.23
+0.25 (+4.18%)
Analyst Consensus
Strong Buy
7
Analysts
Moderate
Coverage
Buy 6 86%
Hold 1 14%
Sell 0 0%
Price Target
Analyst Price Target +465.8% upside
Low Target $27.20
Average Target $35.25
High Target $53.45
Current Price $6.23
Current
$6.23
Target
$35.25
$27.20 $35.25 avg $53.45
Scenario Analysis
Bear Case
$27.20
336.6%
Low target
Base Case
$35.25
+465.8%
Avg target
Bull Case
$53.45
+757.9%
High target
Risk/Reward
2.3x
Favorable
Price in Context
52-Week High
$15.74
-60.4% from high
52-Week Low
$1.55
+301.9% from low
Target vs 52W High
$35.25
+124.0% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Strong Buy 38 82% $257.58 -12.5%
AMGN
Amgen Inc
Hold 42 43% $190.87 -59.0%
GILD
Gilead Sciences Inc
Strong Buy 36 83% $362.68 +115.4%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 39 82% $438.34 -18.5%
MRNA
Moderna Inc
Hold 31 32% $149.45 -35.4%
REGN
Regeneron Pharmaceuticals
Buy 36 72% $76.80 -91.9%
NTRA
Natera Inc
Strong Buy 31 90% $142.91 -55.7%
RVMD
Revolution Medicines Inc
Strong Buy 31 94% $114.11 -35.3%